Patient Guide: A 2-year Study of EYP-1901 in Subjects With Wet Age Related Macular Degeneration (wAMD) (LUGANO) Primary Efficacy Will be Determined at Week 56

Why Use Quri.ai for This Trial?

  • ✓ Simplified eligibility checker - know if you qualify in minutes
  • ✓ Direct contact with study coordinators at 85 locations
  • ✓ Plain language explanations of medical terms and procedures
  • ✓ Personalized enrollment support throughout your journey
  • ✓ Free service - no hidden fees or obligations
Trial ID: NCTNCT06668064
Status: ACTIVE_NOT_RECRUITING
Condition: Wet Age Related Macular Degeneration, wAMD
Phase: PHASE3

Where You Can Participate

This study is available at 85 locations across the country.

Top locations include:
  • • Phoenix, Arizona
  • • Springdale, Arkansas
  • • Bakersfield, California
  • • And 82 more locations

Loading interactive enrollment tools...

The full interactive experience will load momentarily

A 2-year Study of EYP-1901 in Subjects With Wet Age Related Macular Degeneration (wAMD) (LUGANO) Primary Efficacy Will be Determined at Week 56 - Join Clinical Trial NCTNCT06668064

How to Join This Clinical Trial - NCTNCT06668064

Learn how to participate in this PHASE3 trial studying an investigational therapy for Wet Age Related Macular Degeneration, wAMD. Current status: ACTIVE_NOT_RECRUITING.

Am I Eligible for This Clinical Trial?

This clinical research study is looking for participants with Wet Age Related Macular Degeneration, wAMD. Eligibility requirements include specific age ranges, health status, and medical history. Contact the study team to learn if you qualify.

Condition Being Studied
Wet Age Related Macular Degeneration, wAMD
Treatment Being Tested
Investigational treatment
Study Phase
PHASE3 - Large-scale efficacy study
Enrollment Status
ACTIVE_NOT_RECRUITING
Study Identifier
NCTNCT06668064 - ClinicalTrials.gov Identifier
Sponsored By
Study sponsor

What to Expect as a Participant

Participating in this clinical trial involves:

  • Initial screening to determine eligibility
  • Regular study visits and health assessments
  • Receiving the study treatment or placebo
  • Medical monitoring and follow-up care
  • Contributing to medical research that may help others
  • Potential access to new treatments before they're widely available

Clinical Trial Benefits and Compensation

Participants in this clinical research study may receive:

  • Close medical monitoring by healthcare professionals
  • Access to potential new treatments
  • Compensation for time and travel (varies by study)
  • No-cost study-related medical care
  • The opportunity to help advance medical knowledge

Where Is This Clinical Trial Located?

This study is enrolling participants at 85 locations. Find a study site near you:

Clinical Research Site

Phoenix, Arizona 85053 - United States

Status: Contact for availability

Clinical Research Site

Springdale, Arkansas 72764 - United States

Status: Contact for availability

Clinical Research Site

Bakersfield, California 93309 - United States

Status: Contact for availability

Clinical Research Site

Beverly Hills, California 90211 - United States

Status: Contact for availability

Clinical Research Site

Glendale, California 91203 - United States

Status: Contact for availability

Clinical Research Site

Irvine, California 92697 - United States

Status: Contact for availability

Clinical Research Site

Poway, California 92064 - United States

Status: Contact for availability

Clinical Research Site

Redlands, California 92374 - United States

Status: Contact for availability

Clinical Research Site

Sacramento, California 95841 - United States

Status: Contact for availability

Clinical Research Site

San Francisco, California 94109 - United States

Status: Contact for availability

And 75 more locations available. Contact us to find the nearest participating site.

How to Enroll in This Study

To learn more about participating in this PHASE3 clinical trial for Wet Age Related Macular Degeneration, wAMD:

  1. Review the eligibility criteria with your healthcare provider
  2. Contact the study team for a pre-screening interview
  3. Schedule an in-person screening visit if eligible
  4. Review and sign the informed consent form
  5. Begin participation in the clinical trial

Why Choose Quri.ai Study Finder

Quri.ai's Study Finder is the leading clinical trial business intelligence platform, helping BD professionals:

  • Discover clinical trials before competitors
  • Access exclusive contact information
  • Track sponsor pipelines and opportunities
  • Connect with decision makers directly
  • Win more business partnerships